Navigation Links
Stem Cell Sciences Enters into Services Agreement with Huntingdon's Disease Research Group, CHDI Foundation Inc.
Date:11/10/2008

a and growth conditions for easy maintenance of CHDI's mouse model ES cell lines, removing a substantial source of experimental variability," said George Murphy, Senior Vice President of SCS LLC. "The deal is a further validation of the quality of SCS' media, and repeat use of CHDI's cell lines is expected to generate further revenue growth from ESGRO Complete(TM)."

"The experience of Stem Cell Sciences in standardising conditions for growing stem cells should help accelerate the evaluation of the various mouse ES cells for HD target validation and drug discovery programs. Working with SCS furthers CHDI's goal of making high quality reagents available to the HD research community," said Dr Jamshid Arjomand, Director of Basic Research at CHDI, overseeing the Foundation's stem cell initiative.

ESGRO Complete(TM) and several other proprietary SCS media products are distributed worldwide under an exclusive licence agreement with Chemicon/Millipore Corporation.

About Stem Cell Sciences plc

Stem Cell Sciences (SCS) is an international research and development company focusing on the commercial application of stem cell biology technologies for drug discovery and regenerative medicine research. Stem Cell Sciences is now focussing on building revenues through the sale of products, collaborative research and licensing deals with international biotechnology and pharmaceutical companies.

Stem Cell Sciences has a substantial portfolio of patents and patent applications in both adult and embryonic stem cell fields. The Company has been active in the stem cell research field since 1994, principally focused on technologies to grow, differentiate, and purify adult and embryonic stem cells. These include technologies to permit the generation of highly purified stem cells and their differentiated progeny (specialised tissue cell types) for use in genetic, pharmacological and toxicological screens. Moreover, these technologies may be able to provide p
'/>"/>

SOURCE Stem Cell Sciences plc
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Deutsche Bank Conference
2. Human Genome Sciences Announces Third Quarter 2008 Financial Results and Key Developments
3. Advanced Life Sciences Announces Third Quarter 2008 Financial Results
4. LI-COR Biosciences and Mandel Scientific Company Inc. Announce Distribution Agreement
5. Vineland Welcomes Dr. Isabelle Lesschaeve as Research Chair, Sensory and Consumer Sciences
6. Human Genome Sciences to Sponsor Conference Call to Discuss Third Quarter 2008 Financial Results
7. Sangamo BioSciences Reports Third Quarter 2008 Financial Results
8. Genomas to Present at Life Sciences & Healthcare Venture Summit
9. Sangamo BioSciences Presents Data at ICAAC Demonstrating In Vivo Protection Against HIV Infection by CCR5-ZFN Therapeutic
10. Neurocrine Biosciences Reports Third Quarter 2008 Results
11. Parion Sciences and Kainos Medicines Sign Clinical Development Agreement for Novel Dry Mouth Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... 2015 Reed Technology and Information ... data management, preparation, and submission to the U.S. Food ... a new Lot Distribution Report (LDR) service for manufacturers ... compliant with the FDA’s new rule on electronic submission ... monitor the volume and timing of particular biologics introduced ...
(Date:4/17/2015)... 2015  Guggenheim Securities, the investment banking and capital ... of William Tanner as a Managing Director ... will start work at Guggenheim in May 2015 in ... "Bill brings a wealth of biotech experience, ... and highly acclaimed healthcare team," said Matthew Johnson ...
(Date:4/17/2015)... April 17, 2015 LC Sciences ... technologies, announced today that it is seeking beta ... innovative multiplex PCR based targeted sequencing technology. The ... analysis, that enables accurate detection of rare variants. ... Omega-Primer™ technologies. The company will collaborate with beta ...
(Date:4/16/2015)... and OSAKA, Japan , April ... Application (CiRA) of Kyoto University and Takeda Pharmaceutical ... work together to develop clinical applications of induced ... failure, diabetes mellitus, neurological disorders and cancer immunotherapy. ... (T-CiRA) is designed to expedite multiple research projects ...
Breaking Biology Technology:Reed Tech Announces FDA Lot Distribution Report (LDR) Service for Manufacturers of Biologic Products 2Reed Tech Announces FDA Lot Distribution Report (LDR) Service for Manufacturers of Biologic Products 3Guggenheim Securities Hires Biotech Analyst William Tanner in Expansion of Healthcare Coverage 2LC Sciences Seeks Beta Testers of Targeted Sequencing Method Ahead of Q4 Launch 2LC Sciences Seeks Beta Testers of Targeted Sequencing Method Ahead of Q4 Launch 3CiRA and Takeda Enter 10-year Collaboration on iPS Cell Research 2CiRA and Takeda Enter 10-year Collaboration on iPS Cell Research 3
... the launch of the FBRM® C35, designed to ... ... ... probe-based FBRM (Focused Beam Reflectance Measurement) technology the ...
... systems in product design and development, manufacture, ... ... Md., Oct. 1 Cylex has announced receipt of,certification ... with the Canadian Medical Devices Conformity Assessment,System (CMDCAS). These ...
... Million Strategic Investment in PharmAthene, ANNAPOLIS, Md., ... a biodefense company developing medical countermeasures,against biological and ... a strategic alliance with Panacea Biotec Ltd., that ... Biotec, through its,subsidiary, Kelisia Holdings Ltd., of $13.1 ...
Cached Biology Technology:Monitor Granule Growth in Process with the FBRM C35 2Cylex(TM) Receives ISO 13485:2003 and 9001:2000 Quality Certifications 2PharmAthene and Panacea Biotec Ltd. Establish Strategic Alliance in Biodefense and Emerging Infectious Diseases 2PharmAthene and Panacea Biotec Ltd. Establish Strategic Alliance in Biodefense and Emerging Infectious Diseases 3PharmAthene and Panacea Biotec Ltd. Establish Strategic Alliance in Biodefense and Emerging Infectious Diseases 4PharmAthene and Panacea Biotec Ltd. Establish Strategic Alliance in Biodefense and Emerging Infectious Diseases 5
(Date:3/24/2015)... 24, 2015 Research and Markets ( ... "Global Iris Recognition Market 2015-2019" report to their ... Recognition market to grow at a CAGR of 23.5 ... covers the present scenario and the growth prospects of ... To calculate the market size, the report considers the ...
(Date:3/24/2015)... , March 24, 2015   Crossmatch ™, ... today announced that its U.are.U ® 4500 ... Goorin Bros . to achieve PCI compliance ... secures access to the POS terminal, protecting the ... of data breaches. With one-third ...
(Date:3/23/2015)... March 23, 2015  In the 2014 fiscal year, ... conviction losses. This figure accounts for a fraction of ... The Nilson Report, exceeds $11 billion globally. The polygraph ... a crime has occurred. Investor Mark Saint Juste ... Joe Paolella partnered to administer the test ...
Breaking Biology News(10 mins):Global Iris Recognition Market 2015-2019 with 3M Cogent, Bioenable Technologies, Cross Match Technology, Iris ID Systems & Safran Dominating 2Crossmatch Fingerprint Readers Help Retailer Prevent Data Breaches at Point-of-Sale 2Polygraph Test Now Used to Protect Investors From Fraud 2Polygraph Test Now Used to Protect Investors From Fraud 3
... (December 16, 2008) The Life Sciences ... recipients. Four Washington State-based research organizations will receive ... million. The newly-funded health research initiatives will focus ... cardiac resuscitation technology, improving the delivery of mental ...
... to do is give quick squeezes as it moves along ... Arizona in Tucson. Scientists had thought DNA-binding proteins ... coded in the DNA,s sequence. Even a protein ... effectively pinpoint sites on DNA using indirect readout, found researcher ...
... , Montreal, December 16, 2008 While ... Michnick is helping the scientific community uncover the basic ... professor and Canada Research Chair in Integrative Genomics, Dr. ... to examine how proteins interact within cells. ...
Cached Biology News:Life Sciences Discovery Fund awards health research program grants 2Life Sciences Discovery Fund awards health research program grants 3Life Sciences Discovery Fund awards health research program grants 4Life Sciences Discovery Fund awards health research program grants 5Just a little squeeze lets proteins assess DNA 2Just a little squeeze lets proteins assess DNA 3Call Stephen Michnick a gene grammarian 2
... Karn (1995) This volume provides ... methods for the study of major HIV ... transcriptase, ribonuclease H, integrase and protease. Expression ... assays; Tat and Rev assays; HIV/CD4 interactions; ...
Mouse TREM-2 Affinity Purified Polyclonal Ab...
Rabbit Anti-Ferret Whole Serum Antibody, Unconjugated...
... versatile liquid handling platforms and flexible robotic ... of life science applications.The Freedom EVO platform ... 100, 150 and 200 cm), giving all ... will advance with their application needs. ...
Biology Products: